Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Former AstraZeneca exec committed insider trading on landmark 2019 Enhertu deal, SEC alleges
Endpoints
Tue, 05/31/22 - 10:39 am
Tags:
AstraZeneca, insider trading, SEC, Enhertu, Daiichi Sankyo
At ESMO, three studies show promise of antibody-drug conjugates in breast cancer
Pharmaforum
Mon, 05/30/22 - 10:23 am
Tags:
ESMO, breast cancer, antibody-drug conjugate, AstraZeneca
Here's What AstraZeneca's Recent FDA News Means for Shareholders
Motley Fool
Mon, 05/30/22 - 10:15 am
Tags:
AstraZeneca, FDA, Imfinzi, tremelimumab, liver cancer
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
Tags:
ASCO 2022, AstraZeneca, Enhertu, Gilead Sciences, Trodelvy, Roche, tiragolumab, cancer
US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf
Endpoints
Wed, 05/25/22 - 11:47 pm
Tags:
Pfizer, HHS, Paxlovid, Merck, molnupiravir, AstraZeneca, Evusheld, COVID-19
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
Yahoo/Zacks.com
Wed, 05/25/22 - 10:36 am
Tags:
AstraZeneca, Europe, EMA, vaccines, COVID-19, boosters, Vaxzevria
At the cusp of NDA filing for lead antibiotic, AstraZeneca spinout goes private at a fraction of IPO price
Endpoints
Mon, 05/23/22 - 06:45 pm
Tags:
AstraZeneca, IPOs, Enstasis, antibiotics
Pfizer, Merck, AstraZeneca led Big Pharma's growth in Q1 but they couldn't match mRNA hotshots
Fierce Pharma
Tue, 05/17/22 - 10:43 am
Tags:
Big Pharma, earnings, Pfizer, Merck, AstraZeneca, COVID-19, Moderna Therapeutics, BioNTech
AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup
Endpoints
Tue, 05/17/22 - 10:36 am
Tags:
AstraZeneca, COVID-19, antibodies, RQ Biotechnology
Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
Tags:
R&D, licensing, M&A, COVID-19, Big Pharma, Bristol Myers Squibb, JNJ, AbbVie, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Roche, GSK, Eli Lilly
Proteros expands oncology collaboration with AstraZeneca
Pharmaceutical Business Review
Tue, 05/17/22 - 10:25 am
Tags:
Proteros, oncology, AstraZeneca, epigenetics
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone
Pharmaforum
Tue, 05/17/22 - 10:23 am
Tags:
BenevolentAI, idiopathic pulmonary fibrosis, AstraZeneca, artificial intelligence, drug development
AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial
Pharmaforum
Mon, 05/16/22 - 10:24 am
Tags:
AstraZeneca, Avillion, clinical trials, calbuterol/budesonide, inhalers, asthma
AZ, Sanofi build case for one-shot RSV antibody
Pharmaforum
Wed, 05/11/22 - 10:31 am
Tags:
AstraZeneca, Sanofi, RSV, nirsevimab
AstraZeneca, FibroGen can't agree on roxadustat's path forward in chronic kidney disease after FDA rejection
Fierce Pharma
Tue, 05/10/22 - 10:40 am
Tags:
AstraZeneca, FibroGen, chronic kidney disease, roxadustat
FDA Approves AstraZeneca, Daiichi Sankyo’s ENHERTU in Breast Cancer
Contract Pharma
Thu, 05/5/22 - 10:40 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, FDA, HER2+ breast cancer, breast cancer
AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer
Pharmaforum
Thu, 05/5/22 - 10:38 am
Tags:
AstraZeneca, Imfinzi, biliary tract cancer, FDA, priority review
AZ bites back at rivals with new Farxiga data in heart failure
Pharmaforum
Thu, 05/5/22 - 10:16 am
Tags:
AstraZeneca, Farxiga, heart failure, clinical trials
AstraZeneca sues Mylan after securing fresh delivery patent on Symbicort
Fierce Pharma
Tue, 05/3/22 - 10:47 am
Tags:
AstraZeneca, patents, legal, Symbicort, Mylan, Kindeva
Ionis, AstraZeneca change a key trial, fueling more questions about a genetic heart disease
BioPharma Dive
Mon, 05/2/22 - 11:03 am
Tags:
Ionis Pharmaceuticals, AstraZeneca, clinical trials, transthyretin amyloid cardiomyopathy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.